Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Evogene (EVGN) Revenue (2016 - 2025)

Historic Revenue for Evogene (EVGN) over the last 14 years, with Q3 2025 value amounting to $312000.0.

  • Evogene's Revenue fell 8206.9% to $312000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year decrease of 2617.74%. This contributed to the annual value of $5.6 million for FY2024, which is 111.7% down from last year.
  • Per Evogene's latest filing, its Revenue stood at $312000.0 for Q3 2025, which was down 8206.9% from $884000.0 recorded in Q2 2025.
  • In the past 5 years, Evogene's Revenue ranged from a high of $4.2 million in Q1 2024 and a low of $135000.0 during Q2 2021
  • For the 5-year period, Evogene's Revenue averaged around $1.1 million, with its median value being $605000.0 (2024).
  • As far as peak fluctuations go, Evogene's Revenue surged by 70836.91% in 2023, and later plummeted by 8206.9% in 2025.
  • Evogene's Revenue (Quarter) stood at $311000.0 in 2021, then soared by 112.22% to $660000.0 in 2022, then dropped by 12.42% to $578000.0 in 2023, then surged by 178.72% to $1.6 million in 2024, then crashed by 80.63% to $312000.0 in 2025.
  • Its Revenue stands at $312000.0 for Q3 2025, versus $884000.0 for Q2 2025 and $2.4 million for Q1 2025.